127 related articles for article (PubMed ID: 8419113)
21. Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes.
Davis SL; McKinnon PS; Hall LM; Delgado G; Rose W; Wilson RF; Rybak MJ
Pharmacotherapy; 2007 Dec; 27(12):1611-8. PubMed ID: 18041881
[TBL] [Abstract][Full Text] [Related]
22. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
[TBL] [Abstract][Full Text] [Related]
23. Ofloxacin in the treatment of lower respiratory tract infections: report of a prospective, comparative trial.
Khajotia RR; Vetter N; Harazin H
Clin Ther; 1991; 13(4):460-6. PubMed ID: 1933997
[TBL] [Abstract][Full Text] [Related]
24. Oral ofloxacin therapy of infections due to multiply-resistant bacteria.
Scully BE; Clynes N; Neu HC
Diagn Microbiol Infect Dis; 1991; 14(5):435-41. PubMed ID: 1797458
[TBL] [Abstract][Full Text] [Related]
25. Oral ofloxacin therapy for invasive external otitis.
Zikk D; Rapoport Y; Redianu C; Shalit I; Himmelfarb MZ
Ann Otol Rhinol Laryngol; 1991 Aug; 100(8):632-7. PubMed ID: 1908200
[TBL] [Abstract][Full Text] [Related]
26. Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: double-blind, multicenter, randomized study.
Tarshis GA; Miskin BM; Jones TM; Champlin J; Wingert KJ; Breen JD; Brown MJ
Antimicrob Agents Chemother; 2001 Aug; 45(8):2358-62. PubMed ID: 11451697
[TBL] [Abstract][Full Text] [Related]
27. Intravenous ofloxacin in severe infections.
Graninger W; Presterl E; Walzl B; Lackner R; Haslinger B; Hackl W
J Antimicrob Chemother; 1990 Nov; 26 Suppl D():123-35. PubMed ID: 2286587
[TBL] [Abstract][Full Text] [Related]
28. Ciprofloxacin: a study of usage in pedal infections with case reports.
Notari MA; Mittler BE
J Foot Surg; 1989; 28(6):521-3. PubMed ID: 2630590
[TBL] [Abstract][Full Text] [Related]
29. Treatment of skin and soft tissue infections with oral ciprofloxacin.
Fass RJ
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():153-7. PubMed ID: 3804903
[TBL] [Abstract][Full Text] [Related]
30. Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections.
Jauregui LE; Babazadeh S; Seltzer E; Goldberg L; Krievins D; Frederick M; Krause D; Satilovs I; Endzinas Z; Breaux J; O'Riordan W
Clin Infect Dis; 2005 Nov; 41(10):1407-15. PubMed ID: 16231250
[TBL] [Abstract][Full Text] [Related]
31. [Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms].
Martínez-Gómez Dde A; Ramírez-Almagro C; Campillo-Soto A; Morales-Cuenca G; Pagán-Ortiz J; Aguayo-Albasini JL
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):317-21. PubMed ID: 19237227
[TBL] [Abstract][Full Text] [Related]
32. Clinical challenges and unmet needs in the management of complicated skin and skin structure, and soft tissue infections.
Turina M; Cheadle WG
Surg Infect (Larchmt); 2005; 6 Suppl 2():S-23-36. PubMed ID: 23577495
[TBL] [Abstract][Full Text] [Related]
33. Treatment of skin and soft-tissue infections with cefsulodin.
Mogabgab WJ
Rev Infect Dis; 1984; 6 Suppl 3():S721-7. PubMed ID: 6400534
[TBL] [Abstract][Full Text] [Related]
34. Oral ciprofloxacin in resistant urinary tract infections.
Ryan JL; Berenson CS; Greco TP; Mangi RJ; Sims M; Thornton GF; Andriole VT
Am J Med; 1987 Apr; 82(4A):303-6. PubMed ID: 3555052
[TBL] [Abstract][Full Text] [Related]
35. [Multicentric study for evaluation of levofloxacin in the treatment of complicated urinary tract infections].
Trinchieri A; Marchetti F
Arch Ital Urol Androl; 2003 Mar; 75(1):49-52. PubMed ID: 12741347
[TBL] [Abstract][Full Text] [Related]
36. [The combination of penicillin G and ofloxacin: a response to the empirical treatment of community acquired pneumonia].
Dopff C; Mertes PM; Nace L; Gerard A; Voiriot P; Preiss MA; May T; Canton P; Dureux JB
Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):526-9. PubMed ID: 2385449
[TBL] [Abstract][Full Text] [Related]
37. Ofloxacin versus trimethoprim/sulfamethoxazole in the treatment of uncomplicated urinary tract infection.
Cox CE; Serfer HS; Mena HR; Briefer C; Childs SJ; Gordon SF; Zoller JS
Clin Ther; 1992; 14(3):446-57. PubMed ID: 1638586
[TBL] [Abstract][Full Text] [Related]
38. Clinical safety and efficacy of ofloxacin.
Marone P; Concia E; Grossi P; Malfitano A; Perversi L
Chemioterapia; 1988 Oct; 7(5):320-2. PubMed ID: 3224401
[TBL] [Abstract][Full Text] [Related]
39. Pefloxacin versus ceftazidime in therapy of soft tissue infections in compromised patients.
Segev S; Rosen N; Pitlik SD; Block C; Rubinstein E
J Antimicrob Chemother; 1990 Oct; 26 Suppl B():193-8. PubMed ID: 2258349
[TBL] [Abstract][Full Text] [Related]
40. Oral ofloxacin therapy for lower respiratory tract infection.
Gentry LO; Lipsky B; Farber MO; Tucker B; Rodriguez-Gomez G
South Med J; 1992 Jan; 85(1):14-8. PubMed ID: 1734527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
